myeloproliferative diseases

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Myeloproliferative Diseases Trial in Bergamo, Pavia (ITF2357)

Completed
  • Myeloproliferative Diseases
  • Bergamo, Italy
  • +1 more
Dec 2, 2019

Myeloproliferative Diseases Trial in Houston (Ruxolitinib, Lenalidomide, Prednisone)

Completed
  • Myeloproliferative Diseases
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 8, 2019

Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)

Terminated
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 24, 2019

Myeloproliferative Diseases Trial in Houston (Ruxolitinib, Pracinostat, Questionnaire)

Completed
  • Myeloproliferative Diseases
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 10, 2019

Myeloproliferative Diseases Trial in Houston (drug, behavioral, procedure)

Terminated
  • Myeloproliferative Diseases
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 4, 2018

Leukemia, Myeloproliferative Diseases Trial in Houston (Clofarabine, Cytarabine)

Completed
  • Leukemia
  • Myeloproliferative Diseases
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 5, 2018

Leukemia, Lymphoma, Myeloma Trial in Houston (Fludarabine, Melphalan, Alemtuzumab)

Terminated
  • Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 18, 2016

Non-Myeloablative Allogeneic Stem Cell Transplantation With

Completed
  • Acute Myeloid Leukemia
  • +10 more
    • San Francisco, California
      University of California San Francisco
    Nov 7, 2012